A 40-year-old man with Addison's disease due to adrenal tuberculosis retained high levels of adrenocorticotropic hormone (ACTH)after conventional hydrocortisone replacement. Plasma ACTHlevels were completely suppressed by usual replacement with hydrocortisone (20 mg at 8:00 and 10 mg at 21:00) but rebounded to abnormally high levels the following morning. Administration of2 mgor 8 mgofdexamethasone suppressed ACTHand cortisol. Magnetic resonance imaging of the brain showed a low-intensity lesion of the pituitary gland. Pituitary hyperplasia or microadenoma with preserved regulation of ACTHwas considered to be the cause of the high plasma ACTHlevels. The combination of hydrocortisone and dexamethasone reduced plasma ACTHlevels. (Internal Medicine 35: 555-559, 1996) 
Introduction
Adrenocorticotropic hormone (ACTH)-producing adenoma secondary to Addison's disease is very rare compared with Nelson' s syndrome after bilateral adrenectomy (1) (2) (3) (4) (5) (6) (7) (8) (9) . In almost all cases, ACTH-producing hyperplasia or adenomamanifested after several years of conventional steroid replacement. Here, we describe a case already demonstrating inappropriate secretion of ACTH when he was diagnosed with Addison's disease. Magnetic resonance imaging of the pituitary gland was performed. Prolonged adrenal insufficiency for up to ten years may lead to hyperplasia or microadenomaof the pituitary cells.
Case Report
A 40-year-old man who had complained of nausea, vomiting and anorexia for two weeks visited Sagae City Hospital and was admitted to the hospital that day. At 21 years of age, he had been admitted for caries of the left 4th toe and was treated for tuberculosis for 3 months. Whenhe was 34 years old, he was also admitted for caries of the lumbar spine and was treated for 3 months. He has been aware of systemic pigmentation for about 10 years. On physical examination, his skin including the mucosal membrane was deeply pigmented. Supine blood pressure was 1 10/80 mmHg. Initial laboratory examination showed hyponatremia, hyperkalemia, anemia, hypoglycemia and leukocytosis with neutrophilia (Table 1) . No tubercle bacillus was detected in the culture of sputa and gastric juice. Abdominal X-ray showed bilateral abdominal calcifications and computed tomography revealed bilateral enlarged calcified adrenal glands ( Fig. 1) . Although plasma cortisol levels were below normal and urinary excretion of 17 hydroxycorticosteroid (17 OHCS) was below normal, ACTHwas elevated (610 pg/ml). He was diagnosed with Addison's disease due to adrenal tuberculosis, and he was treated with hydrocortisone. His clinical features and laboratory data improved rapidly except for ACTH.Even after replacement with 20 mghydrocortisone once a day in the morning, ACTHlevels remained high. He was transferred to Yamagata University Hospital to investigate the cause of high ACTH.Plasma ACTHlevels were persistently suppressed to less than 10 pg/ml by administration of 2 mgor 8 mg dexamethasone (divided into 4 times a day, respectively). Plasma levels of cortisol were suppressed to 1.3 jug/dl either by 2 mg or 8 mg dexamethasone. Suppression of ACTHby 20 mg (once a day) hydrocortisone was insufficient (Fig. 2) . Fromthe results of the dexamethasone-suppression test, we increased the daily doses of hydrocortisone to 30 mg (20 mg at 8:00 and 10 mg at 21:00). Subsequently, 17 OHCS increased to 14.3 mg/day, indicating that hydrocortisone replacement was sufficient. However, in addition to ACTH(665 pg/ml), (3-endorphin (93 pg/ml) remained high in the morning (6:00). Magnetic resonance imaging (MRI) of the brain showed swelling of the right side of the pituitary gland, which was not enhanced by gadolinium-diethylene triamine penta-acetic acid (Gd-DTPA) (Fig. 3 ). Daily profiles of ACTHunder 30 mg hydrocortisone replacement showed that ACTHwas low during the day, but high the next morning (Fig. 2b) . Stimulation tests for several hormones were performed the previous morning without 20 mg hydrocortisone replacement. ACTHand cortisol did not respond to the administration of corticotropin releasing factor (CRF) ( 1 00 \ig, intravenous injection) (Fig. 2c) . Arginine (30 g, intravenous infusion for 30 minutes), luteinizing hormone releasing hormone (LHRH) (100 (ig, intravenous injection) and thyrotropin releasing hormone (TRH) (500 jig, intravenous injection) loading tests showednormal responses of pituitary hormones except for a low response of folliclestimulating hormone (FSH) (Fig. 4) . The results suggest that the suppressive effect of hydrocortisone on ACTH secretion was shorter than usual. This short duration of ACTH suppression could be a characteristic of the pituitary gland in which there appeared hyperplasia or microadenoma and was probably due to a slow degradation of ACTHor to reduced sensitivity in this pituitary, compared to a normal pituitary. Administration of 20 mg hydrocortisone at 8 :00 and 0.25 mg dexamethasone (having a longer half-life of over 200 minutes), at 2 1 :00 instead of 10 mg hydrocortisone (having a shorter half life of approximately 80 minutes), suppressed ACTHto 1 1 8 pg/ ml the next morning (6:00). However, hyponatremia in the morning was induced after the administration of dexamethasone. To prevent hyponatremia, 0.05 mg fludrocortisone acetate was administered at 21:00, and thereafter the serum sodium level was restored to 140 mEq//. There was no significant change in MRIof the brain after the replacement therapy for 6 months but, systemic pigmentation faded during therapy. gland. Prolonged adrenal insufficiency due to conventional but inappropriate hydrocortisone replacement maycause secondary hyperplasia or adenoma of the pituitary gland (2-9). Alternatively, temporary pituitary adrenocortical failure may occur in an ACTH-producingadenoma. Such cases mayhave spontaneous Nelson's syndrome or Cushing's disease without hypercortisolism ( 1 ).
The present case already showed abnormal high levels of ACTH in the morning whenhe was diagnosed with Addison's disease and was treated with 30 mghydrocortisone for over 30 days. Systemic pigmentation apparent for about ten years, and enlargement of adrenal glands suggested mild prolonged adrenal insufficiency, which, in turn, may have induced secondary hyperplasia or adenoma. This resembles the first hypothesis. A similar case has been reported previously (8) , but the ACTH response to dexamethasone in the present case was different. Hydrocortisone was less effective than dexamethasone in suppressing ACTHthe next morning; 0.25 mg dexamethasone is equivalent to 7 mg hydrocortisone. Since dexamethasone has a longer half-life than hydrocortisone, low-dose dexamethasone did suppress ACTH in the morning. Regulation of ACTH secretion in the present case was not completely autonomic. Endocrinologically, ACTH-producing hyperplasia or adenoma in Addison's disease show some degree of autonomy, and may be classified into two types, according to the response of ACTH to dexamethasone. In the first type, ACTHis not completely suppressed by 8 mg dexamethasone/day (4, 8) . This type resembles Nelson's syndrome. In the second type, ACTHis suppressed by hydrocortisone or 8 mg dexamethasone/day (3, 4, 6, 7) , which may be hyperplasia. Transsphenoidal surgery has been performed in a few patients (3, 9) . The histological diagnosis is difficult to confirm. In an operated case of pituitary hyperplasia secondary to Addison 's disease, administration of 8 mg dexamethasone/day suppressed ACTH (9) . In usual cases of Addison's disease, ACTHwas suppressed by 2 mg dexamethasone/day (4). The response is similar to the second type. Autonomyin the second type is less than the first type. From these data, the present case is more likely to be the second type, namely pituitary hyperplasia.
In the present case, the pituitary hormones except for FSH responded well to the corresponding challenges such as arginine, LHRHand TRH loading tests, indicating that other endocrine cells in the pituitary gland were preserved. A poor response of plasma ACTHto CRFhas been reported in pituitary hyperplasia or adenoma in Addison's disease (8, 9) . The response pattern in our case is consistent with previous reports.
Miyabo et al reported that ACTHdoes not respond to CRFin the pre-operative state in pituitary hyperplasia secondary to Addison's disease. However, ACTHresponse to CRFbecame normal in the post-operative state. The excised portion of the pituitary gland was refractory to CRF (9). Shibasaki et al speculated that an ACTHproducing tumor might lose receptors to CRF when it becomes adenomatous (10) . Afew reports of similar cases have shownenlargement of the sella turcica on tomography (6), however, these did not employMRI.In our case the right side of the pituitary gland was enlarged with a slightly lower signal than normal in T1 weighted images. The lesion had poor enhancement by Gd-DTPA, suggesting pituitary hyperplasia or adenoma. Since the pituitary lesion was small and no neurological signs or symptomswere detected, transsphenoidal surgery was not performed. Feek et al reported that 4 of 12 patients with Addison's disease, whowere treated conventionally, showed elevated basal plasma ACTH concentrations, which were partially suppressed by oral administration of either 20 mg hydrocortisone or 25 mgcortisone acetate (ll). If MRIis performed in such cases, pituitary abnormality may be detected with more frequency.
On admission, the present patient had typical symptoms and signs of Addison's disease. Diagnosis was definite from the clinical data. 20 mg hydrocortisone was already administered whenhe was transferred to our hospital. Therefore, a daily profile of ACTHand ACTHresponse to CRFon cessation of medication were not performed.
Insufficient therapy for Addison's disease seems to induce pituitary hyperplasia or adenoma formation. Combination therapy to mimic the normal circadian rhythm of cortisol is necessary to prevent secondary hyperplasia or adenoma (5). Dexamethasone (0.25 mg) at night to inhibit the nocturnal rise of ACTH secretion was effective in another reported case (6).
Here, sufficient hormonal replacement improved pigmentation and suppressed further expansion of the sella turcica. Regression of systemic pigmentation and suppression of sella turcica expansion were observed after six monthsof the combination therapy in this case.
